Integrated Filing — IndAS

General information about company
Scrip Code	534804
NSE Symbol	CARERATING
MSEI Symbol	NA
ISIN	INE752H01013
Name of company	CARE RATINGS LIMITED
Type of company	Main Board
Class of security	Equity
Date of start of financial year	01-Apr-2024
Date of end of financial year	31-Mar-2025
Date of board meeting when results were approved	12-May-2025
Date on which prior intimation of the meeting for considering financial results was informed to the exchange	02-May-2025
Description of presentation currency	INR (in Actuals)
Reporting Type	Quarterly
Reporting Quarter	Fourth quarter
Nature of report standalone or consolidated	Standalone
Whether results are audited or unaudited for the quarter ended	Unaudited
Whether results are audited or unaudited for the Year to date for current period ended/year ended	Audited
Segment Reporting	Single segment
Description of single segment	Rating Business & Others
Start date and time of board meeting	12-May-2025   12:00:00
End date and time of board meeting	12-May-2025   19:00:00
Whether cash flow statement is applicable on company	Yes
Type of cash flow statement	Cash Flow Indirect
Declaration of unmodified opinion or statement on impact of audit qualification	Declaration of unmodified opinion
Whether the company has any related party?	Yes
Whether the company has entered into any Related Party transaction during the selected half year for which it wants to submit disclosure?	Yes
(I) We declare that the acceptance of fixed deposits by the bans/Non-Banking Finance Company are at the terms uniformly applicable/offered to all shareholders/public	NA
(II) We declare that the scheduled commercial bank, as per RBI circular RBI/DBR/2015-16/19 dated March 03, 2016, has allowed additional interest of one per cent per annum, over and above the rate of interest mentioned in the schedule of interest rates on savings or a term deposits of banks staff and their exclusive associations as well as on deposits of Chairman, Chairman & Managing Director, Executive Director or such other Executives appointed for a fixed tenure.	NA
Whether the company is a high value debt listed entity according to regulation 15 (1A)?	No
(a) If answer to above question is Yes, whether complying with proviso to regulation 23 (9), i.e., submitting RPT disclosures on the day of results publication?
(b) If answer to above question is No, please explain the reason for not complying.
Whether the updated Related Party Transactions (RPT) Policy (in compliance with Reg. 23 of SEBI LODR) has been uploaded on the website of the Company?	Yes
Latest Date on which RPT policy is updated	2025-01-30
Indicate Company website link for updated RPT policy of the Company	https://www.careratings.com/
Whether statement on deviation or variation for proceeds of public issue, rights issue, preferential issue, qualified institutions placement etc. is applicable to the company for the current quarter?	No
No. of times funds raised during the quarter
Whether the disclosure for the Default on Loans and Debt Securities is applicable to the entity?	Yes

Financial Results Ind-AS
Particulars		3 months/ 6 months ended (dd-mm-yyyy)	Year to date figures for current period ended (dd-mm-yyyy)
A	Date of start of reporting period	01-Jan-2025	01-Apr-2024
B	Date of end of reporting period	31-Mar-2025	31-Mar-2025
C	Whether results are audited or unaudited	Unaudited	Audited
D	Nature of report standalone or consolidated	Standalone	Standalone
Part I	Blue color marked fields are non-mandatory. For Consolidated Results, if the company has no figures for 3 months / 6 months ended, in such case zero shall be inserted in the said column.
1	Income
	Revenue from operations	912376000	3366850000
	Other income	155127000	513904000
	Total income	1067503000	3880754000
2	Expenses
(a)	Cost of materials consumed	0	0
(b)	Purchases of stock-in-trade	0	0
(c)	Changes in inventories of finished goods, work-in-progress and stock-in-trade	0	0
(d)	Employee benefit expense	375210000	1462386000
(e)	Finance costs	3837000	15833000
(f)	Depreciation, depletion and amortisation expense	19530000	79426000
(f)	Other Expenses
1	Other Expenses	79670000	352944000
	Total other expenses	79670000	352944000
	Total expenses	478247000	1910589000
3	Total profit before exceptional items and tax	589256000	1970165000
4	Exceptional items	0	0
5	Total profit before tax	589256000	1970165000
6	Tax expense
7	Current tax	127390000	483382000
8	Deferred tax	13041000	6847000
9	Total tax expenses	140431000	490229000
10	Net movement in regulatory deferral account balances related to profit or loss and the related deferred tax movement	0	0
11	Net Profit Loss for the period from continuing operations	448825000	1479936000
12	Profit (loss) from discontinued operations before tax	0	0
13	Tax expense of discontinued operations	0	0
14	Net profit (loss) from discontinued operation after tax	0	0
15	Share of profit (loss) of associates and joint ventures accounted for using equity method	0	0
16	Total profit (loss) for period	448825000	1479936000
17	Other comprehensive income net of taxes	3838000	-10344000
18	Total Comprehensive Income for the period	452663000	1469592000
19	Total profit or loss, attributable to
	Profit or loss, attributable to owners of parent
	Total profit or loss, attributable to non-controlling interests
20	Total Comprehensive income for the period attributable to
	Comprehensive income for the period attributable to owners of parent
	Total comprehensive income for the period attributable to owners of parent non-controlling interests
21	Details of equity share capital
	Paid-up equity share capital	299321000	299321000
	Face value of equity share capital	10	10
27	Details of debt securities
22	Reserves excluding revaluation reserve		8279081000
23	Earnings per share
i	Earnings per equity share for continuing operations
	Basic earnings (loss) per share from continuing operations	15	49.49
	Diluted earnings (loss) per share from continuing operations	14.93	49.27
ii	Earnings per equity share for discontinued operations
	Basic earnings (loss) per share from discontinued operations	0	0
	Diluted earnings (loss) per share from discontinued operations	0	0
ii	Earnings per equity share
	Basic earnings (loss) per share from continuing and discontinued operations	15	49.49
	Diluted earnings (loss) per share from continuing and discontinued operations	14.93	49.27
24	Debt equity ratio
25	Debt service coverage ratio
26	Interest service coverage ratio
27	Disclosure of notes on financial results

Remarks
Debt equity ratio
Debt service coverage ratio
Interest service coverage ratio

Statement of Asset and Liabilities
Particulars		Year ended (dd-mm-yyyy)
Date of start of reporting period		01-Apr-2024
Date of end of reporting period		31-Mar-2025
Whether results are audited or unaudited		Audited
Nature of report standalone or consolidated		Standalone
	Assets
1	Non-current assets
	Property, plant and equipment	779692000
	Capital work-in-progress	0
	Investment property	0
	Goodwill	0
	Other intangible assets	148348000
	Intangible assets under development	29240000
	Biological assets other than bearer plants	0
	Investments accounted for using equity method	0
	Non-current financial assets
	Non-current investments	2554913000
	Trade receivables, non-current	0
	Loans, non-current	136024000
	Other non-current financial assets	6670000
	Total non-current financial assets	2697607000
	Deferred tax assets (net)	0
	Other non-current assets	16268000
	Total non-current assets	3671155000
2	Current assets
	Inventories	0
	Current financial asset
	Current investments	0
	Trade receivables, current	224751000
	Cash and cash equivalents	263487000
	Bank balance other than cash and cash equivalents	2162000
	Loans, current	12383000
	Other current financial assets	5489570000
	Total current financial assets	5992353000
	Current tax assets (net)	0
	Other current assets	27666000
	Total current assets	6020019000
3	Non-current assets classified as held for sale	0
4	Regulatory deferral account debit balances and related deferred tax Assets	0
	Total assets	9691174000
	Equity and liabilities
1	Equity
	Equity attributable to owners of parent
	Equity share capital	299321000
	Other equity	8279081000
	Total equity attributable to owners of parent	8578402000
	Non controlling interest
	Total equity	8578402000
2	Liabilities
	Non-current liabilities
	Non-current financial liabilities
	Borrowings, non-current	0
	Trade payables, non-current
	(A) Total outstanding dues of micro enterprises and small enterprises	0
	(B) Total outstanding dues of creditors other than micro enterprises and small enterprises	0
	Total Trade payable	0
	Other non-current financial liabilities	143658000
	Total non-current financial liabilities	143658000
	Provisions, non-current	126267000
	Deferred tax liabilities (net)	66016000
	Deferred government grants, Non-current	0
	Other non-current liabilities	0
	Total non-current liabilities	335941000
	Current liabilities
	Current financial liabilities
	Borrowings, current	0
	Trade payables, current
	(A) Total outstanding dues of micro enterprises and small enterprises	0
	(B) Total outstanding dues of creditors other than micro enterprises and small enterprises	81734000
	Total Trade payable	81734000
	Other current financial liabilities	275300000
	Total current financial liabilities	357034000
	Other current liabilities	374543000
	Provisions, current	34261000
	Current tax liabilities (Net)	10993000
	Deferred government grants, Current	0
	Total current liabilities	776831000
3	Liabilities directly associated with assets in disposal group classified as held for sale	0
4	Regulatory deferral account credit balances and related deferred tax liability	0
	Total liabilities	1112772000
	Total equity and liabilites	9691174000
	Disclosure of notes on assets and liabilities	Textual Information(1)

Text Block

Textual Information(1)

The above results have been reviewed by the Audit Committee and approved by the Board of Directors of the Company at its meeting held on May 12, 2025 and have been audited by the statutory auditors of the Company.The Board of Directors of the Company have recommended final dividend of Rs. 11 per share. The company had earlier paid Rs. 7 per share as interim dividend in Q2 FY25. Accordingly the total dividend for FY25 shall be Rs. 18 per share.During the year, a subsidiary CareEdge Global IFSC Limited has been incorporated on April 29, 2024 and the amount invested in equity share capital of subsidiary is Rs. 3,000 lakhs.The accompanying financial results have been prepared as per the format prescribed under Regulation 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 as modified by Circular No. CIR_CFD_FAC_62_2016 dated July 5, 2016.The financial results have been prepared in accordance with Indian Accounting Standards (Ind AS) notified under the Companies (Indian Accounting Standards) Rules, 2015 (as amended from time to time) read with section 133 of the Companies Act, 2013.The Company has granted 8,11,500 options on various dates (including in previous periods) to the eligible employees of the Company and its subsidiaries under the Company's Employees Stock Option Scheme (ESOS) 2020 which are duly approved by shareholders in AGM and Nomination & Remuneration Committee. As per Ind AS 102 - Share Based Payment, total cost of ESOS 2020 is recognised over vesting period. Share based expenses for Quarter and year ended are Rs.24.66 lakhs and Rs.141.67 lakhs respectively.The figures for the quarter ended March 31, 2024 in the above financial results are the balancing figures between the audited figures for the full financial year ended March 31, 2024 and the year to date unaudited limited reviewed figures published up to the nine months ended December 31, 2023.The figures for the quarter ended March 31, 2025 in the above financial results are the balancing figures between the audited figures for the full financial year ended March 31, 2025 and the year to date unaudited limited reviewed figures published up to the nine months ended December 31, 2024.

Format for Reporting Segmenet wise Revenue, Results and Capital Employed along with the company results
Particulars		3 months/ 6 month ended (dd-mm-yyyy)	Year to date figures for current period ended (dd-mm-yyyy)
Date of start of reporting period		01-Jan-2025	01-Apr-2024
Date of end of reporting period		31-Mar-2025	31-Mar-2025
Whether accounts are audited or unaudited		Unaudited	Audited
Nature of report standalone or consolidated		Standalone	Standalone
1	Segment Revenue (Income)
	(net sale/income from each segment should be disclosed)
	Total Segment Revenue
	Less: Inter segment revenue
	Revenue from operations
2	Segment Result
	Profit (+) / Loss (-) before tax and interest from each segment
	Total Profit before tax
	i. Finance cost
	ii. Other Unallocable Expenditure net off Unallocable income
	Profit before tax
3	(Segment Asset - Segment Liabilities)
	Segment Asset
	Total Segment Asset
	Un-allocable Assets	null	null
	Net Segment Asset	null	null
4	Segment Liabilities
	Segment Liabilities
	Total Segment Liabilities
	Un-allocable Liabilities	null	null
	Net Segment Liabilities	null	null
	Disclosure of notes on segments

Other Comprehensive Income
Particulars		3 months/ 6 months ended (dd-mm-yyyy)	Year to date figures for current period ended (dd-mm-yyyy)
A	Date of start of reporting period	01-Jan-2025	01-Apr-2024
B	Date of end of reporting period	31-Mar-2025	31-Mar-2025
C	Whether results are audited or unaudited	Unaudited	Audited
D	Nature of report standalone or consolidated	Standalone	Standalone
	Other comprehensive income [Abstract]
1	Amount of items that will not be reclassified to profit and loss
1	Items that will not be reclassified to profit or Loss	4380000	-5886000
	Total Amount of items that will not be reclassified to profit and loss	4380000	-5886000
2	Income tax relating to items that will not be reclassified to profit or loss	542000	4458000
3	Amount of items that will be reclassified to profit and loss
	Total Amount of items that will be reclassified to profit and loss
4	Income tax relating to items that will be reclassified to profit or loss	0	0
5	Total Other comprehensive income	3838000	-10344000

Cash flow statement, indirect
Particulars				Year ended (dd-mm-yyyy)
A	Date of start of reporting period			2024-04-01
B	Date of end of reporting period			2025-03-31
C	Whether results are audited or unaudited			Unaudited
D	Nature of report standalone or consolidated			Standalone
Part I	Blue color marked fields are non-mandatory.
	Statement of cash flows
	Cash flows from used in operating activities
	Profit before tax			1970165000
	Adjustments for reconcile profit (loss)
	Adjustments for finance costs			15833000
	Adjustments for decrease (increase) in inventories			0
	Adjustments for decrease (increase) in trade receivables, current			0
	Adjustments for decrease (increase) in trade receivables, non-current			0
	Adjustments for decrease (increase) in other current assets			17072000
	Adjustments for decrease (increase) in other non-current assets			228000
	Adjustments for other financial assets, non-current			0
	Adjustments for other financial assets, current			-112872000
	Adjustments for other bank balances			0
	Adjustments for increase (decrease) in trade payables, current			0
	Adjustments for increase (decrease) in trade payables, non-current			0
	Adjustments for increase (decrease) in other current liabilities			66684000
	Adjustments for increase (decrease) in other non-current liabilities			0
	Adjustments for depreciation and amortisation expense			79426000
	Adjustments for impairment loss reversal of impairment loss recognised in profit or loss			0
	Adjustments for provisions, current			0
	Adjustments for provisions, non-current			0
	Adjustments for other financial liabilities, current			104598000
	Adjustments for other financial liabilities, non-current			0
	Adjustments for unrealised foreign exchange losses gains			0
	Adjustments for dividend income			18093000
	Adjustments for interest income			424445000
	Adjustments for share-based payments			14167000
	Adjustments for fair value losses (gains)			-43634000
	Adjustments for undistributed profits of associates			0
	Other adjustments for which cash effects are investing or financing cash flow			822000
	Other adjustments to reconcile profit (loss)			0
	Other adjustments for non-cash items			5772000
	Share of profit and loss from partnership firm or association of persons or limited liability partnerships			0
	Total adjustments for reconcile profit (loss)			-294442000
	Net cash flows from (used in) operations			1675723000
	Dividends received			0
	Interest paid			0
	Interest received			0
	Income taxes paid (refund)			466646000
	Other inflows (outflows) of cash			0
	Net cash flows from (used in) operating activities			1209077000
	Cash flows from used in investing activities
	Cash flows from losing control of subsidiaries or other businesses			0
	Cash flows used in obtaining control of subsidiaries or other businesses			0
	Other cash receipts from sales of equity or debt instruments of other entities			0
	Other cash payments to acquire equity or debt instruments of other entities			360000000
	Other cash receipts from sales of interests in joint ventures			0
	Other cash payments to acquire interests in joint ventures			0
	Cash receipts from share of profits of partnership firm or association of persons or limited liability partnerships			0
	Cash payment for investment in partnership firm or association of persons or limited liability partnerships			0
	Proceeds from sales of property, plant and equipment			0
	Purchase of property, plant and equipment			99223000
	Proceeds from sales of investment property			0
	Purchase of investment property			0
	Proceeds from sales of intangible assets			0
	Purchase of intangible assets			0
	Proceeds from sales of intangible assets under development			0
	Purchase of intangible assets under development			0
	Proceeds from sales of goodwill			0
	Purchase of goodwill			0
	Proceeds from biological assets other than bearer plants			0
	Purchase of biological assets other than bearer plants			0
	Proceeds from government grants			0
	Proceeds from sales of other long-term assets			31055000
	Purchase of other long-term assets			889351000
	Cash advances and loans made to other parties			0
	Cash receipts from repayment of advances and loans made to other parties			0
	Cash payments for future contracts, forward contracts, option contracts and swap contracts			0
	Cash receipts from future contracts, forward contracts, option contracts and swap contracts			0
	Dividends received			18093000
	Interest received			451890000
	Income taxes paid (refund)			0
	Other inflows (outflows) of cash			128438000
	Net cash flows from (used in) investing activities	-719098000
	Cash flows from used in financing activities
	Proceeds from changes in ownership interests in subsidiaries			0
	Payments from changes in ownership interests in subsidiaries			0
	Proceeds from issuing shares			0
	Proceeds from issuing other equity instruments			0
	Payments to acquire or redeem entity's shares			0
	Payments of other equity instruments			0
	Proceeds from exercise of stock options			40087000
	Proceeds from issuing debentures notes bonds etc			0
	Proceeds from borrowings			0
	Repayments of borrowings			0
	Payments of lease liabilities			15590000
	Dividends paid			538010000
	Interest paid			15833000
	Income taxes paid (refund)			0
	Other inflows (outflows) of cash			0
	Net cash flows from (used in) financing activities			-529346000
	Net increase (decrease) in cash and cash equivalents before effect of exchange rate changes			-39367000
	Effect of exchange rate changes on cash and cash equivalents
	Effect of exchange rate changes on cash and cash equivalents			0
	Net increase (decrease) in cash and cash equivalents			-39367000
	Cash and cash equivalents cash flow statement at beginning of period			302854000
	Cash and cash equivalents cash flow statement at end of period			263487000